Unlock the future of smart pharmacovigilance
Unified. Automated. Intelligent
2
MINS READ
- Overview Press tab for submenu items
TCS is here to make a difference through technology.
Leading the way in innovation for over 55 years, we build greater futures for businesses across multiple industries and 55 countries.
-
Industries
-
Services
-
Products and Platforms
- Overview Press tab for submenu items
We deliver excellence and create value for customers and communities.
Our expert, committed team put our shared values into action – every day. With the best talent and the latest technology we help customers turn complexity into opportunities and create meaningful change.
-
About Us
-
Research & Innovation
-
Our Brand
- Overview Press tab for submenu items
Extraordinary expertise leads to remarkable results.
We share news, insights, analysis and research – tailored to your unique interests – to help you deepen your knowledge and impact.
-
Customer Stories
-
Perspectives
-
Global studies
-
Topics
- Overview Press tab for submenu items
Want to be a global change-maker? Join our team.
At TCS, we believe exceptional work begins with hiring, celebrating and nurturing the best people — from all walks of life.
-
India
-
Americas
-
Asia Pacific
-
Europe and UK
-
Middle East and Africa
Overview
India
expand here
Americas
expand here
Asia Pacific
expand here
Europe and UK
expand here
Middle East and Africa
expand here
- Overview Press tab for submenu items
Find the latest news about TCS in our Newsroom
Get access to a catalog of the latest news stories from across TCS. Discover our press releases, reports, and company announcements.
-
Press releases
-
News alerts
-
Analyst recognition
-
Events
-
Media kit
- Overview Press tab for submenu items
TCS works hand in hand with world-leading investors.
Tata Consultancy Services LimitedNSE:TCSINR -
Management Commentary
-
Financials
-
News and Events
-
ESG
-
Resources
Overview
Management Commentary
expand here
Financials
expand here
News and Events
expand here
ESG
expand here
Resources
expand here
- Worldwide Press tab for submenu items
Global knowledge. Local support
At TCS, we help enterprises grow through innovative solutions globally. Adapt and thrive with us.
-
Global
-
Localized
Top Results
Showing
10
01 - 07
Products and platforms
TCS ADD™
This will open an overlay
TCS ADD™: A Suite of Modern and Open Technology Platforms
TCS ADD™ is a suite of modern and open technology platforms for clinical research and drug development that helps make clinical trials more agile and safe.
Related Insights
This paper dives into how AI technology is unifying fragmented clinical data to make clinical trials more patient-centric, effective, safer, and efficient.
Article
20 May 2025
Hosted by TCS ADD™, the invite-only event will see leaders talk about the role of AI/Generative AI in life sciences. Register for the leadership forum now.
Events
14 Feb 2025
Join us at the life sciences event to learn how AI and generative AI can accelerate next-gen clinical R&D and enhance patient safety. Register now for the event.
Events
07 Aug 2024
2021 has been a challenging year for life sciences organizations amidst the COVID-19 pandemic. There has been an ever-increasing volume of safety cases with diverse sources of safety information, better public awareness on the safety of medicinal products, and unprecedented demand for information and responses. As a result, the pharmacovigilance approach has been forced to evolve, innovate, and adopt efficient solutions, and leverage smart technologies to operate and manage patient safety data effectively as well as efficiently.
At TCS ADD Safety, we were pleased to host an industry-mapped panel that focused its discussion on key areas that enable seamless adoption of smart pharmacovigilance and the role of AI in improving patient safety. In addition, our panelists at the virtual event also discussed how to enable safety case processing in pharmacovigilance through a technology-led approach. Shared below is the high-level snapshot of thematic areas that were discussed at the virtual event.
- Leveraging AI as a scalable approach to handle safety case volume
- Handling complexities in safety reports with AI
- Achieving compliance when using artificial intelligence in pharmacovigilance
- Increasing efficiencies with enhanced quality and accuracy
- Sharing real-life experiences of enabling artificial intelligence in pharmacovigilance – lessons learnt and way forward
We are happy to have onboarded, revered panelists who have been responsible for transforming pharmacovigilance in their organizations through industry-first initiatives.
Speakers
- Michael Murphy, Executive Director and Head of Pharmacovigilance Operations, Amgen
- Bharathish Rao, Associate Director, Patient Safety Systems (CMO Organization), AstraZeneca
- Arpita Bhowmick, Global Director, Omni Channel Contact Center Technology, Moderna
- Dr. Mangesh Kulkarni, Medical Director and Head of PV, TCS
- [Moderator] Dr. Alejandra Guerchicoff, Industry Leader, TCS ADD Safety, TCS
Highlights
Ready-to-deploy modular solutions, including energy, water, transportation, enterprise resilience, sustainability, and command center
AI- and ML-enhanced city and enterprise systems for optimized operational sustainability, resilience, and efficiency
Analytics-enabled cognitive operations and enhanced contextual recommendations for real-time decision insights
Related reading
Swipe Left
Swipe Right
What’s on your mind?
We’re here to help! Tell us what you’re looking for and we’ll get you connected to the right people.
Looking for something else?
©2025 TATA Consultancy Services Limited
©2025 TATA Consultancy Services Limited
- Privacy Notice
- Cookie Policy
- Accessibility Declaration
- Disclaimer
- Security Policy
- California Notice at Collection
- Customize Cookies
